← Back to Search

Procedure

Continuous Positive Airway Pressure use for Altitude Hypoxia

N/A
Waitlist Available
Led By Brian M Strickland, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial explored using CPAP devices to reduce dyspnea and oxygen levels in individuals travelling at high altitudes, with promising results. It was found that CPAP devices are lightweight, portable, and can be powered by batteries; allowing for easier delivery to individuals in need of rescue.

Eligible Conditions
  • Altitude Hypoxia
  • Low Oxygen Levels

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart rate
Peripheral oxygen saturation
Respiratory rate

Side effects data

From 2020 Phase 4 trial • 74 Patients • NCT01807897
16%
Increased dyspnea
6%
Excessive sleepiness
3%
Heart failure
3%
Fall
3%
Stroke
3%
Bronchitis
3%
Pneumonia
3%
Toothache
3%
Skin infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
CPAP
Oxygen
HLSE

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Continuous Positive Airway Pressure useExperimental Treatment1 Intervention
Group II: Ambient airPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Continuous positive airway pressure
2016
Completed Phase 4
~1710

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,734 Previous Clinical Trials
2,148,858 Total Patients Enrolled
Brian M Strickland, MDPrincipal InvestigatorUC Denver

Media Library

Continuous Positive Airway Pressure (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05971290 — N/A
Altitude Hypoxia Research Study Groups: Continuous Positive Airway Pressure use, Ambient air
Altitude Hypoxia Clinical Trial 2023: Continuous Positive Airway Pressure Highlights & Side Effects. Trial Name: NCT05971290 — N/A
Continuous Positive Airway Pressure (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05971290 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the criteria to be enrolled in this clinical trial?

"Patients who have low levels of oxygen and are between 18-70 years old may be qualified to join this research study. Up to 25 individuals will gain entry into the experiment."

Answered by AI

Does the protocol for this research endeavor stipulate an age cap?

"This research study requires that participants are between 18 and 70 years old in order to be considered for enrollment."

Answered by AI

Is access to this research project currently available for participants?

"As stated on clinicaltrials.gov, this medical trial is no longer recruiting patients; it was first published on July 22nd 2019 and its last update occurred a few days later on the 24th of that same month. Fortunately, there are 133 active trials seeking enrolment at present moment."

Answered by AI
~14 spots leftby Apr 2025